▼Quinupristin + dalfopristin for infections

doi:10.1136/dtb.2002.40215

DTB

2002;40:15-16 doi:10.1136/dtb.2002.40215

Articles

▼Quinupristin + dalfopristin for infections

Relevant BNF section: 5.1.7

Abstract

&#9660Quinupristin + dalfopristin* (Synercid-Aventis Pharma Ltd) is a new combination antibacterial product licensed for treating patients with a variety of Gram-positive infections. Here we assess its place in clinical practice.

Footnotes

This Article

Abstract
Full text
PDF

Services

Email this link to a friend
Alert me when this article is cited
Alert me if a correction is posted
Alert me when eletters are published
Similar articles in this journal
Similar articles in Web of Science
Similar articles in PubMed
Add article to my folders
Download to citation manager
Request permissions

Responses

Submit a response
No responses published

Register for email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

DTB archive now live

The DTB archive back to 1962, volume 1, issue 1 is now available:
View the archive

▼Quinupristin + dalfopristin for infections

Abstract

Footnotes

This Article

Services

Responses

Citing articles

Google Scholar

PubMed

Related Content

Social bookmarking

Register for email alerts

DTB archive now live